133 related articles for article (PubMed ID: 35528914)
1. Synthesis and biological evaluation of 3-nitro-4-chromanone derivatives as potential antiproliferative agents for castration-resistant prostate cancer.
Chen H; Xing Y; Xie J; Xie J; Xing D; Tang J; Yang F; Yi Z; Qiu WW
RSC Adv; 2019 Oct; 9(58):33794-33799. PubMed ID: 35528914
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel diterpenoid analogs with in-vivo antitumor activity.
Wang YY; He Y; Yang LF; Peng SH; He XL; Wang JH; Lv F; Hao Y; Liu MY; Yi Z; Qiu WW
Eur J Med Chem; 2016 Sep; 120():13-25. PubMed ID: 27187855
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosterone derivatives as antitumor agents.
Cui HW; Peng S; Gu XZ; Chen H; He Y; Gao W; Lv F; Wang JH; Wang Y; Xie J; Liu MY; Yi Z; Qiu WW
Eur J Med Chem; 2016 Mar; 111():126-37. PubMed ID: 26866967
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of Cyanoenone-Modified Diterpenoid Analogs as Novel Bmi-1-Mediated Antitumor Agents.
Yang LF; Xing Y; Xiao JX; Xie J; Gao W; Xie J; Wang LT; Wang J; Liu M; Yi Z; Qiu WW
ACS Med Chem Lett; 2018 Nov; 9(11):1105-1110. PubMed ID: 30429953
[TBL] [Abstract][Full Text] [Related]
5. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer.
Shi SJ; Wang LJ; Han DH; Wu JH; Jiao D; Zhang KL; Chen JW; Li Y; Yang F; Zhang JL; Zheng GX; Yang AG; Zhao AZ; Qin WJ; Wen WH
Theranostics; 2019; 9(5):1247-1263. PubMed ID: 30867828
[No Abstract] [Full Text] [Related]
7. Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage.
Zhang DF; Yang ZC; Chen JQ; Jin XX; Qiu YD; Chen XJ; Shi HY; Liu ZG; Wang MS; Liang G; Zheng XH
BMC Complement Med Ther; 2021 Jul; 21(1):195. PubMed ID: 34229670
[TBL] [Abstract][Full Text] [Related]
8. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.
Ma B; Zhang H; Wang Y; Zhao A; Zhu Z; Bao X; Sun Y; Li L; Zhang Q
J Exp Clin Cancer Res; 2018 Sep; 37(1):210. PubMed ID: 30176898
[TBL] [Abstract][Full Text] [Related]
9. The synthesis and antitumor activity of lithocholic acid and its derivatives.
He XL; Xing Y; Gu XZ; Xiao JX; Wang YY; Yi Z; Qiu WW
Steroids; 2017 Sep; 125():54-60. PubMed ID: 28648585
[TBL] [Abstract][Full Text] [Related]
10. Diastereoselective synthesis of 3,3-disubstituted 3-nitro-4-chromanone derivatives as potential antitumor agents.
Chen H; Xie J; Xing D; Wang J; Tang J; Yi Z; Xia F; Qiu WW; Yang F
Org Biomol Chem; 2019 Jan; 17(5):1062-1066. PubMed ID: 30638240
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel tanshinone derivatives for treatment of castration-resistant prostate cancer.
Xu D; Hu H; Guan J; Da J; Xie Y; Liu Y; Kong R; Song G; Zhou H
Chem Biol Drug Des; 2019 Sep; 94(3):1656-1663. PubMed ID: 31108007
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
Ren S; Liu Y; Xu W; Sun Y; Lu J; Wang F; Wei M; Shen J; Hou J; Gao X; Xu C; Huang J; Zhao Y; Sun Y
J Urol; 2013 Dec; 190(6):2278-87. PubMed ID: 23845456
[TBL] [Abstract][Full Text] [Related]
13. Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer.
Chen S; Nimick M; Cridge AG; Hawkins BC; Rosengren RJ
Int J Oncol; 2018 Feb; 52(2):579-588. PubMed ID: 29207190
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Biological Evaluation, and Mode of Action of
Fang Y; Hu D; Li H; Hu J; Liu Y; Li Z; Xu G; Chen L; Jin Y; Yang S; Yang Z
Front Pharmacol; 2019; 10():1208. PubMed ID: 31680978
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Discovery and Optimization of Benzo[ d]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC).
Zhang M; Zhang Y; Song M; Xue X; Wang J; Wang C; Zhang C; Li C; Xiang Q; Zou L; Wu X; Wu C; Dong B; Xue W; Zhou Y; Chen H; Wu D; Ding K; Xu Y
J Med Chem; 2018 Apr; 61(7):3037-3058. PubMed ID: 29566488
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel N-alkyl 4-anilinofuro[2,3-b]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers.
Lo WF; Chou YW; Tseng CH; Shiu YH; Chen YW; Yang SC; Chen YL; Lin MF; Tzeng CC
Anticancer Agents Med Chem; 2015; 15(4):493-500. PubMed ID: 25612680
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives.
Lee CC; Huang KF; Lin PY; Huang FC; Chen CL; Chen TC; Guh JH; Lin JJ; Huang HS
Eur J Med Chem; 2012 Jan; 47(1):323-36. PubMed ID: 22100139
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative Properties of 7,8-Ethylene Diamine Chelator-Lipophilic Fluoroquinolone Derivatives Against Colorectal Cancer Cell Lines.
Khaleel S; Al-Hiari Y; Kasabri V; Haddadin R; Albashiti R; Al-Zweri M; Bustanji Y
Anticancer Agents Med Chem; 2022; 22(5):1012-1028. PubMed ID: 34165411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
